Menu

Yeast Infection Study

Study Closed

Title of Study:

Acute Yeast Infection study

Short Title:

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

Study Length: up to 29 days

Target Age/Sex: 18 years, female

Benefits:

Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov